Home > Healthcare > Medical Devices > Diagnostic Devices > Blood Transfusion Diagnostics Market

Blood Transfusion Diagnostics Market Share

Report ID: GMI5607
Published Date: May 2023
Report Format: PDF

Download Free Sample

Blood Transfusion Diagnostics Market Share

Some of the major market players operating in the blood transfusion diagnostics industry are:

Abbott Laboratories
BAG Healthcare GmBH
Bio-Rad Laboratories, Inc
Danaher Corporation
Diagnostica Stago
DiaSorin S.p.A., F.
Hoffmann-La Roche Ltd
Grifols S.A.
Hologic, Inc.
Immucor Inc
Merck KGaA
Ortho Clinical Diagnostics
Quotient Ltd
Thermo Fisher Scientific Inc.

These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Blood transfusion diagnostics industry size was USD 4.6 billion in 2022 and will reach USD 8.8 billion by 2032 due to the growing burden of chronic diseases and blood related disorders.

Blood transfusion diagnostics market share from reagents & kits reached USD 3 billion in 2022 owing to the incessant need for precise and accurate screening as well as management of blood transfusion diagnostics.

Demand for blood transfusion diagnostics in the U.S. recorded USD 1.8 billion in 2022 and will significantly grow through 2023-2032 on account of the surging healthcare expenditure in the region.

Abbott Laboratories, BAG Healthcare GmBH, Bio-Rad Laboratories, Inc, Diagnostica Stago, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Grifols S.A., Merck KGaA, Ortho Clinical Diagnostics, Quotient Ltd and Thermo Fisher Scientific Inc. are some well-known blood transfusion diagnostic industry players.